CD44, CD133 and LGR5 are characteristic cell surface markers of glioma CSCs (Lathia et al., 2015), which are either receptors for cWnt pathway (LGR5), or function as positive regulators of Wnt receptors (CD44; Schmitt et al., 2015), or E-cadherin (CD133; Brossa et al., 2018). The gene discussed is PROM1; the disease is central nervous system cancer.